Features, pricing, ratings, and pros and cons, compared head to head.
Armis Centrix™ for VIPR is a commercial medical device security tool by Armis. UncommonX Asset Discovery and Management is a commercial cyber asset attack surface management tool by UncommonX. Compare features, ratings, integrations, and community reviews side by side to find the best medical device security fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output. Mid-market and enterprise teams struggling to see what's actually connected to their network will find UncommonX Asset Discovery and Management's agentless approach cuts through the noise without deployment friction. Its passive integration with NetFlow and syslog means you get visibility without agents to manage, and the NIST ID.AM and ID.RA coverage reflects a tool purpose-built for asset inventory and risk correlation rather than incident response. Skip this if you need continuous threat detection or behavioral analytics; UncommonX excels at telling you what you own and which assets matter, not what those assets are currently doing.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output.
UncommonX Asset Discovery and Management
Mid-market and enterprise teams struggling to see what's actually connected to their network will find UncommonX Asset Discovery and Management's agentless approach cuts through the noise without deployment friction. Its passive integration with NetFlow and syslog means you get visibility without agents to manage, and the NIST ID.AM and ID.RA coverage reflects a tool purpose-built for asset inventory and risk correlation rather than incident response. Skip this if you need continuous threat detection or behavioral analytics; UncommonX excels at telling you what you own and which assets matter, not what those assets are currently doing.
Healthcare-focused vuln mgmt platform for medical device security & risk prioritization
Agentless asset discovery and management platform for network visibility
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Armis Centrix™ for VIPR vs UncommonX Asset Discovery and Management for your medical device security needs.
Armis Centrix™ for VIPR: Healthcare-focused vuln mgmt platform for medical device security & risk prioritization. built by Armis. Core capabilities include Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization..
UncommonX Asset Discovery and Management: Agentless asset discovery and management platform for network visibility. built by UncommonX. Core capabilities include Agentless discovery of network devices and systems, Operating system and patch level identification, Installed software and version detection..
Both serve the Medical Device Security market but differ in approach, feature depth, and target audience.
Armis Centrix™ for VIPR differentiates with Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization. UncommonX Asset Discovery and Management differentiates with Agentless discovery of network devices and systems, Operating system and patch level identification, Installed software and version detection.
Armis Centrix™ for VIPR is developed by Armis. UncommonX Asset Discovery and Management is developed by UncommonX. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Armis Centrix™ for VIPR and UncommonX Asset Discovery and Management serve similar Medical Device Security use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox